Intravenous solutions are fluids that are intended to be injected directly into the venous circulation of individual patients who have deficiency in nutrients or suffer from serious cases of dehydration. The solutions are administered on to the patients whose body nutrients or fluid level falls beneath the standard requirement. These hypotonic intravenous solutions are available in the market in various types for usage. Various companies provide packaged intravenous fluids or products to be mixed with sterile water in order to prepare a solution to be administered into the patient.

Another cause of fluid volume can be blood loss. As they are consumed directly by the patient during such precarious situation, it is made under very strict regulations by the governments to ensure top-class results and constant availability at clinics, hospitals, and at home. The market demand for this product is surging ahead due to the rising prevalence of chronic diseases and a growing acceptance of Vitamin-C intravenous treatment therapy for treating colorectal cancer.

The global Intravenous solution market valuation is forecasted to reach USD 11,511.2 million by the end of the review period with a CAGR of 7.69% forecast period. As mentioned previously, intravenous solutions are given to patients who are struggling with fluid volume level and deficiency of body nutrients. There are a number of reasons that can cause a drop in the fluid volume. Diarrhea and vomiting are two classic examples of the same, wherein individuals are encouraged to drink more fluids to balance out the electrolytes present in their body.

Competitive Landscape

The intravenous solution market includes various prominent and leading market players, the names of some of which are mentioned herein: Grifols S.A. (Spain), Fresenius Kabi AG (Germany), ICU Medical, Inc. (U.S.), Terumo Medical Corporation (Tokyo), B. Braun Melsungen AG (Germany), Baxter (U.S.), Amanta Healthcare (India), and others.

Market Segmentation

The global intravenous solution market is segmented in the following basis: type, end-users, and nutritional content.

Based on Bag Type, the IV solutions market has been bifurcated into large volume bags (>250 ml) and small volume bags (<250 ml).
Based on Nutritional Content, the IV solutions market has been segregated into amino acid solution, vitamins & minerals, carbohydrates, parenteral lipid emulsion, and others.
Based on End user, the market is segregated into hospitals & clinics, ambulatory surgical centers, and home care.

Regional Analysis

The global intravenous solution market is growing at a steady pace. The regional market segmentation of intravenous solutions covers the following regions: Asia-Pacific, North America, Europe, and the Middle East & Africa.

As of 2015, North America held the largest market share of intravenous solutions. The regional market is expected to reach a market valuation of USD 6,543.4 million by the end of the forecast period at 2022. The growing market demand in this region can be attributed to factors such as the increasing acceptance of Vitamin C intravenous therapy treatment for colorectal cancer and the wide-spread prevalence of chronic diseases.

Europe holds the second spot in terms of the market share percentage and is expected to grow at desirable pace of 8.12% CAGR during the forecast period of 2016 to 2022. The Asia-Pacific regional market is believed to be fastest of the lot with a projected CAGR of 8.34% during the review period.

The intravenous solution market in the APAC region is predicted to have a healthy growth over the forecast period. Factors aiding growth in the region include cost advantage, constantly expanding population base, government initiatives, growing private funds, and the emergence of better and high-quality institutions and healthcare infrastructure.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: [email protected]